Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a specific type of non-invasive breast condition called ductal breast carcinoma in situ (DCIS), or with early-to-intermediate stage invasive breast cancer (stage I, II, or III) that has occurred without a known hereditary cause and only on one side of the body
- People who are able to speak, read, or write in English
Who may not be able to join:
- People who have had breast cancer before
- People who have previously had both breasts surgically removed as a preventive measure
- People who are known to carry a gene mutation that increases the risk of breast cancer (such as BRCA1 or BRCA2), or who are considered to have a high risk of developing cancer in the other breast based on a strong family history of cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Abenaa M Brewster, M.D. Anderson Cancer Center
Phone: 713-745-4949
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acceptability of the decision support tool; Changes in patient's knowledge of contralateral prophylactic mastectomy (CPM); Reductions in decisional conflict about CPM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.